Personalized Medicine – News and Features

DxS K-RAS test will assist US oncologists in studying patient response to cancer therapies in clinical trials.

A new high throughput microscopy technique enabled researchers at Baylor College of Medicine to analyze thousands of individual cells expressing androgen receptor.

A new report by a presidential advisory council says that personalized medicine—treatment based on an understanding of each patient’s unique physical makeup, including genetic structure—could significantly improve healthcare.

The agreements cover the licensing of certain X-MAN cell lines and the screening of a number of Agios lead compounds on a wide panel of genotypes.

Horizon Discovery (Horizon) today announced it has signed two commercial agreements with a ground-breaking U.S. cancer start-up; Agios Pharmaceuticals (Agios), relating to its X-MAN technology.

The five year agreement provides quantitative biomarker evaluation to predict cancer treatment responses to targeted therapies.

AssureRx gets access to Diamond's managerial and clinical expertise, accelerating the development of AssureRx’s personalized medicine product for behavioral healthcare.

The first Arab human genome has been sequenced, as part of a large project to map the unique genetic variations of the Arab population.

PMC has applauded statements issued by both parties’ campaigns endorsing the principles of personalized medicine and its role in improving healthcare.

The Institute has awarded more than $20 million in grants to develop inexpensive sequencing technologies to sequence a person's DNA as a routine part of biomedical research.